Bengaluru: Aurobindo Pharma Ltd, India’s third largest drugmaker by revenue, posted an about 3% rise in quarterly profit on Wednesday, but missed analysts’ estimates.

Profit was Rs595 crore ($92.6 million) in the third quarter ended 31 December, compared with 5.79 billion rupees a year earlier, the Hyderabad-headquartered drugmaker said.

Analysts on average had expected a profit of Rs671 crore, Thomson Reuters data showed.

Total revenue from operations rose 11% to Rs4,336 crore.

The Aurobindo Pharma shares closed 3.44% up at Rs616.75 on BSE.